| Capecitabine studied in …STUDIED_INderived200 of 1,386show all (up to 200) |
|---|
| → studied in | NCT00726687Phase 1/Phase 2 · completed Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · 1,386 trials list this drug (362 active) | — | — | Gastrin-Producing Neuroendocrine Tumor,Pancreatic Glucagonoma,Pancreatic Insulinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02598349Phase 2 · recruiting Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04495296Phase 1/Phase 2 · active not recruiting A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05803382Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers · 1,386 trials list this drug (362 active) | — | — | Malignant Solid Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847229Phase 2 · not yet recruiting A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847710Phase 2 · recruiting Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial · 1,386 trials list this drug (362 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03653507Phase 3 · active not recruiting A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW). · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03734029Phase 3 · completed Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · 1,386 trials list this drug (362 active) | — | — | Esophageal Neoplasm,Gastric Neoplasm,Gallbladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787339Phase 2 · recruiting Capecitabine in Low Risk Triple Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060807Phase 3 · recruiting A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610163Phase 2/Phase 3 · active not recruiting Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06312176Phase 3 · recruiting A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393374Phase 3 · recruiting Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966700Phase 3 · recruiting A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007559Phase 2 · recruiting ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05152147Phase 3 · active not recruiting A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers · 1,386 trials list this drug (362 active) | — | — | Gastric Neoplasm,Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863195Phase 3 · recruiting Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial · 1,386 trials list this drug (362 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06018337Phase 3 · active not recruiting A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06123338Phase 2 · recruiting A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Esophageal Neoplasm,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06901531Phase 3 · recruiting A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07069712Phase 2 · recruiting A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma · 1,386 trials list this drug (362 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824934Phase 1 · recruiting HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899155Phase 2 · recruiting Pan Tumor Rollover Study · 1,386 trials list this drug (362 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400695Phase 3 · recruiting A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2 · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · 1,386 trials list this drug (362 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Malignant Biliary Tract Neoplasm,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837362Phase 2 · not yet recruiting SCRT Combined With CAPOX and PD-1/CTLA4 Antibody for Early-stage Low Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829757Phase 4 · not yet recruiting A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829783Phase 3 · not yet recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055) · 1,386 trials list this drug (362 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828756Phase 2 · not yet recruiting Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00905047Phase 3 · completed Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03585465Phase 1/Phase 2 · terminated Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629597Phase 3 · active not recruiting A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) · 1,386 trials list this drug (362 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824869Phase 2 · not yet recruiting A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer Patients · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061515Phase 1 · active not recruiting Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06324357Phase 1/Phase 2 · recruiting Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm,Esophageal Adenocarcinoma,Gastric Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246344Phase 3 · active not recruiting Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730373Phase 2 · recruiting First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Gastric Carcinoma,HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04166318Phase 2 · active not recruiting Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · 1,386 trials list this drug (362 active) | — | — | Anal Basaloid Carcinoma,Anal Canal Squamous Cell Carcinoma,Anal Margin Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · 1,386 trials list this drug (362 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma,Oligometastatic Esophageal Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818070Phase 3 · not yet recruiting A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma · 1,386 trials list this drug (362 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm,Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Gastric Adenocarcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06247995Phase 1/Phase 2 · active not recruiting A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764875Phase 3 · recruiting A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer · 1,386 trials list this drug (362 active) | — | — | Gastroesophageal Junction Adenocarcinoma,HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673887Phase 3 · recruiting A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer · 1,386 trials list this drug (362 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07790445Phase 4 · recruiting A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract Tumors · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03424005Phase 1/Phase 2 · recruiting A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661150Phase 2 · completed A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04721977Phase 2 · active not recruiting A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797635Phase 2 · recruiting Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652242Phase 1 · recruiting Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907475Phase 2 · recruiting Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial · 1,386 trials list this drug (362 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05633654Phase 3 · recruiting Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037980Phase 2/Phase 3 · recruiting CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence · 1,386 trials list this drug (362 active) | — | — | Malignant Biliary Tract Neoplasm,Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07431281Phase 3 · recruiting Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · 1,386 trials list this drug (362 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07679360Phase 3 · recruiting A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01591733Phase 2 · completed FOLFIRINOX + RT for Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805551Phase 1/Phase 2 · recruiting A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05568095Phase 3 · completed A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06245889Phase 2 · recruiting PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07413939Phase 2/Phase 3 · recruiting RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive · 1,386 trials list this drug (362 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801027Phase 4 · not yet recruiting A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) · 1,386 trials list this drug (362 active) | — | — | Malignant Neoplasm,Gastric Neoplasm,Biliary Tract Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801352Phase 2 · active not recruiting CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04276493Phase 1/Phase 2 · completed Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · 1,386 trials list this drug (362 active) | — | — | Pancreatic Neuroendocrine Carcinoma,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05585814Phase 2 · active not recruiting CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06469944Phase 1/Phase 2 · recruiting Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) · 1,386 trials list this drug (362 active) | — | — | Esophageal Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024615Phase 1 · recruiting A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer · 1,386 trials list this drug (362 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791758Phase 1/Phase 2 · not yet recruiting A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma · 1,386 trials list this drug (362 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05126719Phase 2 · active not recruiting A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma · 1,386 trials list this drug (362 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01081262Phase 3 · active not recruiting Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer · 1,386 trials list this drug (362 active) | — | — | Borderline Ovarian Mucinous Tumor,Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04379596Phase 2 · active not recruiting Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05700084Phase 1/Phase 2 · active not recruiting Phase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00642603Phase 2 · terminated A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03615326Phase 3 · completed Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) · 1,386 trials list this drug (362 active) | — | — | Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222215Phase 2 · recruiting PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958328Phase 3 · recruiting Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02008656Phase 2 · active not recruiting Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399110Phase 3 · completed XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801876Phase 3 · active not recruiting Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer · 1,386 trials list this drug (362 active) | — | — | Thoracic Esophagus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05104866Phase 3 · active not recruiting A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554521Phase 2 · recruiting A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States · 1,386 trials list this drug (362 active) | — | — | Esophageal Squamous Cell Carcinoma,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01918527Phase 3 · completed Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03764553Phase 2 · active not recruiting Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741644Phase 1/Phase 2 · recruiting A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07631052Phase 2 · recruiting Capecitabine in ER+/HER2-negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02955940Phase 2 · active not recruiting An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04158258completed A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04246684Phase 3 · active not recruiting Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942626Phase 1 · completed Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766772Phase 2 · not yet recruiting Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01677884Phase 2 · completed Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy · 1,386 trials list this drug (362 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04768426Phase 2 · recruiting Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06139211Phase 1/Phase 2 · completed A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06525766Phase 2 · recruiting Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm,HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926868Phase 2/Phase 3 · recruiting A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502393Phase 1 · active not recruiting A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01494155Phase 2 · completed Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07737600Phase 1/Phase 2 · not yet recruiting A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745296Phase 3 · not yet recruiting Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04556773Phase 1 · active not recruiting A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210971Phase 2 · active not recruiting Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06281886Phase 2 · completed Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma · 1,386 trials list this drug (362 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06949111Phase 2 · recruiting Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color） · 1,386 trials list this drug (362 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057089Phase 2 · suspended Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I) · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05464030Phase 1 · active not recruiting Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009069Phase 2 · active not recruiting A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Rectal Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07580339Phase 2 · not yet recruiting Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02445391Phase 3 · active not recruiting Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595424Phase 2 · active not recruiting Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas · 1,386 trials list this drug (362 active) | — | — | Gastric Neuroendocrine Carcinoma,Intestinal Neuroendocrine Carcinoma,Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615013Phase 1 · recruiting NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer · 1,386 trials list this drug (362 active) | — | — | Gastroesophageal Junction Adenocarcinoma,Cervical Esophagus Adenocarcinoma,Thoracic Esophagus Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094893Phase 4 · not yet recruiting Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07582315Phase 3 · recruiting A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) · 1,386 trials list this drug (362 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07606599Phase 3 · recruiting A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure · 1,386 trials list this drug (362 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06343948Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01) · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06382142Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02) · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07648914Phase 3 · recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04158362Phase 3 · active not recruiting Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895358Phase 3 · active not recruiting Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340567Phase 3 · active not recruiting Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281768Phase 2 · recruiting Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07709767Phase 2 · not yet recruiting Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma · 1,386 trials list this drug (362 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04523818Phase 1 · active not recruiting Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma · 1,386 trials list this drug (362 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205485Phase 3 · recruiting Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04443348Phase 2 · active not recruiting Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06112379Phase 3 · active not recruiting A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690787Phase 2 · recruiting JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06109779Phase 3 · active not recruiting Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) · 1,386 trials list this drug (362 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009449Phase 1 · completed A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692152Phase 3 · recruiting Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma · 1,386 trials list this drug (362 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691333Phase 2 · not yet recruiting Kumorixilib Plus Capecitabine and Letrozole for Neoadjuvant Treatment of HR-Positive HER2-Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05507112Phase 2 · active not recruiting TIME in Immunotherapy Combined With nCRT for Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621484Phase 2 · not yet recruiting HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684456Phase 3 · not yet recruiting Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07685704Phase 2 · not yet recruiting Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma,HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05064085Phase 1 · completed Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06839105Phase 1 · recruiting A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies · 1,386 trials list this drug (362 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836584Phase 2 · active not recruiting Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer · 1,386 trials list this drug (362 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06630130Phase 2 · recruiting Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer · 1,386 trials list this drug (362 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07679399Phase 2 · recruiting A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer. · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06507371Phase 3 · active not recruiting Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07056777Phase 1/Phase 2 · recruiting Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677293Phase 3 · not yet recruiting Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780787Phase 2 · recruiting FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04649385Phase 1 · completed BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05144854Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07385703Phase 3 · recruiting Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma. · 1,386 trials list this drug (362 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06884670Phase 2 · completed Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867121Phase 1 · completed A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Lung Non-Small Cell Carcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07655661Phase 2 · not yet recruiting Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer. · 1,386 trials list this drug (362 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929028Phase 2 · active not recruiting Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · 1,386 trials list this drug (362 active) | — | — | Anal Squamous Cell Carcinoma,AIDS-Related Anal Carcinoma,Anal Margin Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05629585Phase 3 · active not recruiting A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04607421Phase 3 · active not recruiting A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05235542Phase 1/Phase 2 · completed A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors · 1,386 trials list this drug (362 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628504Phase 3 · not yet recruiting Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590024Phase 3 · recruiting RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma · 1,386 trials list this drug (362 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04753879Phase 2 · active not recruiting Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618078recruiting Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC · 1,386 trials list this drug (362 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07622797Phase 2 · recruiting Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04198727Phase 2 · active not recruiting Study of the Impact of DPD Activity on the Efficacy of Capecitabine · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07456852Phase 1/Phase 2 · recruiting Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy · 1,386 trials list this drug (362 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07622017Phase 2 · not yet recruiting KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213002Phase 1/Phase 2 · recruiting Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM · 1,386 trials list this drug (362 active) | — | — | Malignant Neoplasm,Glioblastoma,Adult Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04296162Phase 2 · completed Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07461454Phase 3 · recruiting YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04564898Phase 1/Phase 2 · active not recruiting Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients. · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07331155Phase 2 · recruiting A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)] · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05374512Phase 3 · active not recruiting A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02) · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02514278Phase 3 · completed Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05702229Phase 2 · recruiting Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432295Phase 2 · recruiting Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) · 1,386 trials list this drug (362 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07113275Phase 3 · recruiting A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365592Phase 1/Phase 2 · recruiting Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07390383Phase 2 · recruiting A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04] · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04864067Phase 2 · completed No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06081959Phase 3 · recruiting Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06279364Phase 3 · recruiting A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07071337Phase 3 · recruiting A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201859Phase 2 · active not recruiting Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma · 1,386 trials list this drug (362 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06761417Phase 2 · recruiting A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults · 1,386 trials list this drug (362 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03523312Phase 2 · active not recruiting Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570914Phase 2 · not yet recruiting Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00953537NA · completed Predicting Response to Capecitabine in Women With Metastatic Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034251Phase 2 · terminated Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis · 1,386 trials list this drug (362 active) | — | — | Malignant Gastric Neoplasm,Gastric Adenocarcinoma,Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503756Phase 2 · recruiting JS212 Combination Therapies in Metastatic Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561060Phase 1/Phase 2 · recruiting Low Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab Immunotherapy · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562659Phase 2 · recruiting Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562711Phase 2 · recruiting Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734290Phase 1/Phase 2 · active not recruiting Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204094Phase 2 · recruiting Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392320Phase 2 · recruiting A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma · 1,386 trials list this drug (362 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549906Phase 2 · not yet recruiting Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study · 1,386 trials list this drug (362 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551479Phase 3 · not yet recruiting SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00885066Phase 1 · completed Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03756298Phase 2 · active not recruiting Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07239466Phase 2 · recruiting A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer · 1,386 trials list this drug (362 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07494448Phase 1/Phase 2 · not yet recruiting Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04595565Phase 3 · active not recruiting Sacituzumab Govitecan in Primary HER2-negative Breast Cancer · 1,386 trials list this drug (362 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |